These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27413112)

  • 21. In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software.
    Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
    Regul Toxicol Pharmacol; 2005 Dec; 43(3):313-23. PubMed ID: 16242226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of QSAR models for the prediction of ames genotoxicity: a retrospective exercise on the chemical substances registered under the EU REACH regulation.
    Cassano A; Raitano G; Mombelli E; Fernández A; Cester J; Roncaglioni A; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2014; 32(3):273-98. PubMed ID: 25226221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantum mechanical quantitative structure activity relationships to avoid mutagenicity in dental monomers.
    Yourtee D; Holder AJ; Smith R; Morrill JA; Kostoryz E; Brockmann W; Glaros A; Chappelow C; Eick D
    J Biomater Sci Polym Ed; 2001; 12(1):89-105. PubMed ID: 11334192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applicability domains for classification problems: Benchmarking of distance to models for Ames mutagenicity set.
    Sushko I; Novotarskyi S; Körner R; Pandey AK; Cherkasov A; Li J; Gramatica P; Hansen K; Schroeter T; Müller KR; Xi L; Liu H; Yao X; Öberg T; Hormozdiari F; Dao P; Sahinalp C; Todeschini R; Polishchuk P; Artemenko A; Kuz'min V; Martin TM; Young DM; Fourches D; Muratov E; Tropsha A; Baskin I; Horvath D; Marcou G; Muller C; Varnek A; Prokopenko VV; Tetko IV
    J Chem Inf Model; 2010 Dec; 50(12):2094-111. PubMed ID: 21033656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Searching for an enhanced predictive tool for mutagenicity.
    Klopman G; Zhu H; Fuller MA; Saiakhov RD
    SAR QSAR Environ Res; 2004 Aug; 15(4):251-63. PubMed ID: 15370416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Ames Mutagenicity Using Conformal Prediction in the Ames/QSAR International Challenge Project.
    Norinder U; Ahlberg E; Carlsson L
    Mutagenesis; 2019 Mar; 34(1):33-40. PubMed ID: 30541036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. coral Software: QSAR for Anticancer Agents.
    Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
    Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative structure-activity relationship modeling of polycyclic aromatic hydrocarbon mutagenicity by classification methods based on holistic theoretical molecular descriptors.
    Gramatica P; Papa E; Marrocchi A; Minuti L; Taticchi A
    Ecotoxicol Environ Saf; 2007 Mar; 66(3):353-61. PubMed ID: 16616369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project.
    Furuhama A; Kitazawa A; Yao J; Matos Dos Santos CE; Rathman J; Yang C; Ribeiro JV; Cross K; Myatt G; Raitano G; Benfenati E; Jeliazkova N; Saiakhov R; Chakravarti S; Foster RS; Bossa C; Battistelli CL; Benigni R; Sawada T; Wasada H; Hashimoto T; Wu M; Barzilay R; Daga PR; Clark RD; Mestres J; Montero A; Gregori-Puigjané E; Petkov P; Ivanova H; Mekenyan O; Matthews S; Guan D; Spicer J; Lui R; Uesawa Y; Kurosaki K; Matsuzaka Y; Sasaki S; Cronin MTD; Belfield SJ; Firman JW; Spînu N; Qiu M; Keca JM; Gini G; Li T; Tong W; Hong H; Liu Z; Igarashi Y; Yamada H; Sugiyama KI; Honma M
    SAR QSAR Environ Res; 2023; 34(12):983-1001. PubMed ID: 38047445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations.
    Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T
    Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CORAL: building up the model for bioconcentration factor and defining it's applicability domain.
    Toropov AA; Toropova AP; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    Eur J Med Chem; 2011 Apr; 46(4):1400-3. PubMed ID: 21295893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Merging applicability domains for in silico assessment of chemical mutagenicity.
    Liu R; Wallqvist A
    J Chem Inf Model; 2014 Mar; 54(3):793-800. PubMed ID: 24494696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity: QSAR - quasi-QSAR - nano-QSAR.
    Toropova AP; Toropov AA
    Mini Rev Med Chem; 2015; 15(8):608-21. PubMed ID: 25694078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the OECD QSAR Application Toolbox and Toxtree for estimating the mutagenicity of chemicals. Part 1. Aromatic amines.
    Devillers J; Mombelli E
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):753-69. PubMed ID: 21120760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quasi-QSAR for mutagenic potential of multi-walled carbon-nanotubes.
    Toropov AA; Toropova AP
    Chemosphere; 2015 Apr; 124():40-6. PubMed ID: 25465947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained.
    Barber C; Cayley A; Hanser T; Harding A; Heghes C; Vessey JD; Werner S; Weiner SK; Wichard J; Giddings A; Glowienke S; Parenty A; Brigo A; Spirkl HP; Amberg A; Kemper R; Greene N
    Regul Toxicol Pharmacol; 2016 Apr; 76():7-20. PubMed ID: 26708083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
    Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
    SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure activity analysis of azo dyes and related compounds.
    Claxton LD; Walsh DB; Esancy JF; Freeman HS
    Prog Clin Biol Res; 1990; 340B():11-22. PubMed ID: 2203001
    [No Abstract]   [Full Text] [Related]  

  • 39. A topological substructural molecular design approach for predicting mutagenesis end-points of alpha, beta-unsaturated carbonyl compounds.
    Pérez-Garrido A; Helguera AM; López GC; Cordeiro MN; Escudero AG
    Toxicology; 2010 Jan; 268(1-2):64-77. PubMed ID: 20004227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts.
    Toropov AA; Toropova AP; Benfenati E; Salmona M
    Toxicol Mech Methods; 2018 Jun; 28(5):321-327. PubMed ID: 29281931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.